MEDIHALER-EPI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Medihaler-epi, and when can generic versions of Medihaler-epi launch?
Medihaler-epi is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER-EPI is epinephrine bitartrate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the epinephrine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEDIHALER-EPI?
- What are the global sales for MEDIHALER-EPI?
- What is Average Wholesale Price for MEDIHALER-EPI?
Summary for MEDIHALER-EPI
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| DailyMed Link: | MEDIHALER-EPI at DailyMed |
US Patents and Regulatory Information for MEDIHALER-EPI
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | MEDIHALER-EPI | epinephrine bitartrate | AEROSOL, METERED;INHALATION | 010374-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
